论文部分内容阅读
目的探讨尿激酶对急性脑梗死患者的神经功能缺损改善的临床疗效。方法将2012年1月-2013年1月间我院收治的92例急性脑梗死患者随机分为观察组和对照组各46例,对照组采用常规治疗措施,观察组则在常规治疗基础上加用尿激酶溶栓治疗,对两组患者的疗效和神经功能缺损改善情况进行统计对比。结果观察组总有效率显著高于对照组,神经缺损功能评分恢复情况优于对照组,差异有统计学意义(P<0.05)。结论尿激酶溶栓治疗急性脑梗死疗效显著,相较于单纯采用常规治疗有着明显的优势,值得临床推广应用。
Objective To investigate the clinical efficacy of urokinase in improving neurological deficits in patients with acute cerebral infarction. Methods A total of 92 patients with acute cerebral infarction admitted to our hospital from January 2012 to January 2013 were randomly divided into observation group and control group, 46 cases in each group. The control group was treated with routine treatment, while the observation group was treated with routine treatment Thrombolytic therapy with urokinase, the two groups of patients with improved efficacy and neurological deficit compared statistically. Results The total effective rate in the observation group was significantly higher than that in the control group, and the recovery of functional impairment of nerve defect was better than that of the control group (P <0.05). Conclusion Urokinase thrombolytic therapy for acute cerebral infarction significant effect, compared with the simple use of conventional treatment has obvious advantages, worthy of clinical application.